Compare Robinhood Markets, Inc. (HOOD) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Robinhood Markets, Inc. vs Natera Inc. Common Stock — how do they compare? Robinhood Markets, Inc. trades at $98.28 (market cap $90.88B), while Natera Inc. Common Stock trades at $393.93 (market cap $57.03B). The key difference: Robinhood Markets, Inc. is the larger of the two by market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Robinhood Markets, Inc. for 75 Days and Natera Inc. Common Stock for 0 Days on average.
| HOOD | NTRA | |
|---|---|---|
Market Cap | $90.88B | $57.03B |
Volume | 23,337,832 | 1,131,157 |
Sector | Financials | Health |
52-Week High | $147.08 | $425.64 |
52-Week Low | $65.16 | $179.42 |
Typical Hold Time | 75 Days | 0 Days |
Enterprise Value | $97.42B | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Robinhood (HOOD) trades at $110.52, up 1.19% with a neutral technical signal. The company shows strong fundamentals with 2025 revenue of $4.47B and net income of $1.88B, though valuation metrics remain elevated (P/E 48.9, P/S 20.61). Recent news highlights expansion into 24/7 trading and AI-powered features, while earnings show mixed quarterly performance with two beats and one miss in the last four quarters.
Analyst consensus remains bullish with 74% buy ratings and a $138.60 price target, representing 25% upside potential. Key risks include high valuation multiples, competitive pressures in online brokerage, and regulatory scrutiny. The company's transformation into a broader financial services platform provides growth opportunities but requires careful execution.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
